UNC5C inhibitors belong to a class of chemical compounds that specifically target and inhibit the activity of the UNC5C receptor, which is a member of the UNC5 family of netrin receptors. The UNC5C receptor is a key player in cell signaling pathways that regulate processes such as cell migration, adhesion, and apoptosis. UNC5C is a transmembrane receptor that typically binds to netrin-1, a guidance cue for axonal growth and other cellular navigation mechanisms. When activated by netrin-1, the UNC5C receptor can mediate either cell survival or apoptosis, depending on the cellular context and the availability of co-receptors or additional ligands. UNC5C inhibitors function by disrupting the interaction between UNC5C and its ligands, such as netrin-1, leading to the modulation of downstream signaling pathways involved in cellular responses to environmental cues.
Structurally, UNC5C inhibitors can vary widely, but they typically possess features that enable them to bind specifically to the extracellular domain or intracellular signaling regions of the UNC5C receptor, thereby altering its functional state. Some inhibitors act by preventing receptor dimerization or the recruitment of intracellular adaptor proteins, which are essential for downstream signaling. These chemical compounds may interfere with various secondary messengers involved in UNC5C-mediated signaling, such as kinases, phosphatases, or small GTPases, depending on the specific mode of inhibition. Research into UNC5C inhibitors often focuses on identifying the molecular dynamics of receptor-ligand interactions and elucidating the structural properties of inhibitors that lead to selective binding and functional alteration of the receptor. These studies are crucial for understanding the biochemical mechanisms governing UNC5C receptor regulation and the broader implications for cellular signaling networks.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This nucleoside analog could lead to DNA demethylation, specifically reducing transcriptional activity of the UNC5C gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
By being incorporated into DNA, 5-Aza-2′-Deoxycytidine may inhibit DNA methyltransferase activity, thereby potentially downregulating UNC5C gene expression through hypomethylation. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Directly targeting DNA methyltransferases, RG 108 could lower methylation levels of the UNC5C promoter, driving a decrease in gene transcription. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
As a histone deacetylase inhibitor, this compound could enhance chromatin openness around the UNC5C locus, leading to transcriptional repression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
This compound may reduce UNC5C expression by inhibiting histone deacetylases, which can result in a condensed chromatin state less conducive to transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid's inhibition of histone deacetylases could repress UNC5C expression by altering histone acetylation and decreasing gene accessibility. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This inhibitor may decrease UNC5C transcription by promoting a tightly packed chromatin structure via histone deacetylase inhibition. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Through activation of retinoic acid receptors, Retinoic acid could initiate a transcriptional repression cascade that diminishes UNC5C gene expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
By disrupting folate metabolism and subsequent DNA methylation processes, Methotrexate could downregulate UNC5C expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound may inhibit RNA polymerase directly, leading to a targeted decrease in UNC5C mRNA synthesis. | ||||||